drug
ATROPINE SULFATE
Marketedupdated 3mo agoby Paragon BioTeck, Inc.
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- drugDIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE164 co-mentions · 54 sources
- tagApproval140 co-mentions · 48 sources
- drugatropine120 co-mentions · 54 sources
- drugAtropen120 co-mentions · 54 sources
- drugAtropine Sulfate Intas120 co-mentions · 54 sources
- tagSmall Molecule44 co-mentions · 22 sources
- tagDrug Shortage5 co-mentions · 5 sources
- companySpecGx LLC4 co-mentions · 2 sources
all catalysts(12)
approval · 12
Sep 29, 2020
approval
ATROPINE SULFATE — FDA approval
ATROPINE SULFATE
→
Oct 6, 2020
approval
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE (ATROPINE SULFATE) — FDA approval
ATROPINE SULFATE
→
Jul 26, 2021
approval
ATROPINE SULFATE — FDA approval
ATROPINE SULFATE
→
Nov 26, 2021
approval
ATROPINE SULFATE — FDA approval
ATROPINE SULFATE
→
Nov 23, 2022
approval
ATROPINE SULFATE — FDA approval
ATROPINE SULFATE
→
Apr 7, 2023
approval
ATROPINE SULFATE — FDA approval
ATROPINE SULFATE
→
Feb 18, 2025
approval
ATROPINE SULFATE — FDA approval
ATROPINE SULFATE
→
Oct 24, 2025
approval
ATROPINE SULFATE — FDA approval
ATROPINE SULFATE
→
Feb 4, 2026
approval
ATROPINE SULFATE — FDA approval
ATROPINE SULFATE
→
Mar 9, 2026
approval
ATROPINE SULFATE — FDA approval
ATROPINE SULFATE
→
Mar 18, 2026
approval
ATROPINE SULFATE — FDA approval
ATROPINE SULFATE
→
Mar 27, 2026
approval
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE (ATROPINE SULFATE) — FDA approval
ATROPINE SULFATE
→
Trials studying ATROPINE SULFATE
- phase1Phase I Clinical Trial to Evaluate the Safety and Tolerability of Ophtalmic Solution PRO-201
- phase1Sublingual Atropine Bioequivalence by Route of Administration (SABER)
- phase3Atropine in the Treatment of Myopia Study in Malaysia
- phase3A Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops
- phase3A Phase III Clinical Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops
- phase3The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatric Myopia Progression
- phase3Study of Atropine Sulfate Eye Drops(0.01%) in Treating Near-work-induced Transient Myopia in Children
- phase1Safety and Tolerability Evaluation of PRO-230 Ophthalmic Solution
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 17m ago
Found something off?
comments(0)
5-min edit window · permanent after that